EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor

Yosuke Kogue, Shunya Ikeda, Yuto Maehara, Ryuhei Kawamoto, Makiko Suga, Shuhei Kida, Kumi Shibata, Kazuhito Tsutsumi, Hiraku Murakami, Emiko Mizuta, Yo Mizutani, Yuta Yamaguchi und 2 weitere

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04191-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Yosuke Kogue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Ltd., Minoh, Osaka, 562-0029, Japan. Hauptthemen laut MEDLINE: Killer Cells, Natural, Fetal Blood, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cord blood (CB)-derived chimeric antigen receptor (CAR) natural killer (NK) cells have demonstrated significant antitumor efficacy. We recently reported that CB-derived CAR NK cells predominantly originate from CD7+CD56-CD34-HLA-DR-Lin- NK cell precursors in CB. Here, we demonstrate that stimulating the interleukin (IL)-15 receptor on these NK precursors enhances the production of CAR NK cells from CB cells. In CB CD56-CD34-HLA-DR-Lin- cells, the IL-15 receptor was exclusively expressed on CD7+ NK cell precursors. Using K562 feeder cells that express not only 4-1BB ligand and membrane-bound (mb) IL-21 but also mbIL-15 significantly increased the production of mature NK cells from the purified NK cell precursors or T cell-depleted CB cells. The in vitro and in vivo antitumor effects of CAR NK cells generated using K562 feeder cells that express mbIL-15 were comparable to those of CAR NK cells produced using K562 feeder cells that do not express mbIL-15. These results suggest that K562 feeder cells expressing 4-1BBL, mbIL-21, and mbIL-15 can increase the production of CAR NK cells from CB cells while maintaining their cytotoxic potential. This method could also be useful for expanding NK cells from CB for any type of adoptive NK cell therapy with or without CAR transduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalFetal BloodReceptors, Chimeric AntigenImmunotherapy, AdoptiveReceptors, Interleukin-15HumansAnimalsK562 CellsMice4-1BB LigandInterleukin-21Mice, SCIDFeeder CellsInterleukinsInterleukin-15Mice, Inbred NOD

Stichwörter der Autor:innen

Adoptive cell therapyCAR NK cellCord bloodIL-15NK cellProgenitor cell

Substanzen

Receptors, Chimeric AntigenReceptors, Interleukin-154-1BB LigandInterleukin-21InterleukinsInterleukin-15

Autor:innen und Institutionen

  • Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Ltd., Minoh, Osaka, 562-0029, Japan.
  • Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
  • World Premier International Immunology Frontier Research Center, The University of Osaka, Suita, Osaka, 565-0871, Japan.
  • Department of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
  • Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, 565-0871, Japan.
  • Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. hnaoki@bldon.med.osaka-u.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Kogue, Y., Ikeda, S., Maehara, Y., Kawamoto, R., Suga, M., Kida, S., Shibata, K., Tsutsumi, K., Murakami, H., Mizuta, E., Mizutani, Y., Yamaguchi, Y., Okuzaki, D., & Hosen, N. (2025). CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04191-0

Vancouver

Kogue Y, Ikeda S, Maehara Y, Kawamoto R, Suga M, Kida S, et al. CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04191-0

BibTeX
@article{Kogue2025,
  author = {Kogue, Yosuke and Ikeda, Shunya and Maehara, Yuto and Kawamoto, Ryuhei and Suga, Makiko and Kida, Shuhei and Shibata, Kumi and Tsutsumi, Kazuhito and Murakami, Hiraku and Mizuta, Emiko and Mizutani, Yo and Yamaguchi, Yuta and Okuzaki, Daisuke and Hosen, Naoki},
  title = {CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04191-0}
}
Kostenlos starten →